Mayinglong Pharmaceutical Group Co Ltd (600993) — Financial Flexibility Index
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Financial Flexibility Index of 0.17x as of September 2025. Free cash flow of CN¥152.93 Million (operating CF CN¥139.20 Million minus capex CN¥13.73 Million) represents 0% of total liabilities (CN¥909.82 Million). Check Mayinglong Pharmaceutical Group Co Ltd (600993) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mayinglong Pharmaceutical Group Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Mayinglong Pharmaceutical Group Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see Mayinglong Pharmaceutical Group Co Ltd cash flow conversion.
Annual Financial Flexibility Index for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Mayinglong Pharmaceutical Group Co Ltd. Explore Mayinglong Pharmaceutical Group Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥719.82 Million | CN¥600.44 Million | CN¥921.49 Million | ▲ +9.2% |
| 2024 | 0.72x | CN¥701.46 Million | CN¥497.61 Million | CN¥980.66 Million | ▼ -19.5% |
| 2023 | 0.89x | CN¥852.43 Million | CN¥604.07 Million | CN¥959.62 Million | ▲ +206.6% |
| 2022 | 0.29x | CN¥416.86 Million | CN¥341.85 Million | CN¥1.44 Billion | ▼ -64.4% |
| 2021 | 0.81x | CN¥662.27 Million | CN¥597.17 Million | CN¥812.72 Million | ▲ +128.3% |
| 2020 | 0.36x | CN¥328.40 Million | CN¥282.99 Million | CN¥919.89 Million | ▼ -56.8% |
| 2019 | 0.83x | CN¥537.94 Million | CN¥491.58 Million | CN¥650.49 Million | ▲ +42.6% |
| 2018 | 0.58x | CN¥333.21 Million | CN¥308.24 Million | CN¥574.67 Million | ▼ -29.7% |
| 2017 | 0.82x | CN¥398.08 Million | CN¥356.17 Million | CN¥482.99 Million | ▲ +29.7% |
| 2016 | 0.64x | CN¥304.84 Million | CN¥239.60 Million | CN¥479.88 Million | ▲ +8.4% |
| 2015 | 0.59x | CN¥306.78 Million | CN¥182.85 Million | CN¥523.31 Million | ▲ +30.6% |
| 2014 | 0.45x | CN¥218.54 Million | CN¥111.67 Million | CN¥486.89 Million | ▼ -3.1% |
| 2013 | 0.46x | CN¥213.62 Million | CN¥129.94 Million | CN¥461.22 Million | ▼ -6.1% |
| 2012 | 0.49x | CN¥202.01 Million | CN¥169.25 Million | CN¥409.56 Million | ▲ +38.7% |
| 2011 | 0.36x | CN¥120.06 Million | CN¥75.37 Million | CN¥337.70 Million | ▲ +416.9% |
| 2010 | 0.07x | CN¥22.13 Million | CN¥-11.42 Million | CN¥321.68 Million | ▼ -89.5% |
| 2009 | 0.65x | CN¥251.05 Million | CN¥216.11 Million | CN¥384.11 Million | ▲ +40.7% |
| 2008 | 0.46x | CN¥135.43 Million | CN¥102.59 Million | CN¥291.46 Million | ▲ +256.0% |
| 2007 | 0.13x | CN¥31.13 Million | CN¥6.49 Million | CN¥238.53 Million | ▼ -66.1% |
| 2006 | 0.39x | CN¥96.59 Million | CN¥75.27 Million | CN¥250.53 Million | ▼ -28.3% |
| 2005 | 0.54x | CN¥94.38 Million | CN¥58.43 Million | CN¥175.45 Million | ▼ -15.4% |
| 2004 | 0.64x | CN¥83.13 Million | CN¥54.19 Million | CN¥130.74 Million | ▲ +5.9% |
| 2003 | 0.60x | CN¥82.05 Million | CN¥67.52 Million | CN¥136.61 Million | — |